Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Vaccine Development
New Vaccine Targets Identified For Cancer-Causing Strains Of Human Papillomavirus
April 11th, 2001
An international collaboration of scientists has announced new vaccine targets for cancer-causing strains of the human papillomavirus (HPV). Researchers at Epimmune Inc. (EPMN), with Loyola University, Chicago, Illinois; Leiden University Medical Center, The Netherlands; and University of Wales College of Medicine, Wales, U.K., reported in the March 27, 2001, issue of the Journal of Clinical Cancer Research the discovery of four epitopes (protein fragments) from the virus that can induce a cellular immune response in human cells in vitro and may lead to an effective vaccine for treatment and prevention of cervical intraepithelial neoplasia (CIN), pre-cancerous...
Source: Vaccine Weekly (2001-04-11)
|
